Developer docs
API playgroundTry for free, no card

Search company profiles

Zuuka Group

Full company profile

uuid002qq74

Namestring
Zuuka Group
Legal namestring
Zuuka Limited
Websiteurl
zuuka.com
Company typeenum
Private
Founded yearint
2001
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOffenbach, Germany
HQ citystring
Offenbach
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
wearable drug infusion, medical device development, drug delivery systems, infusion technology, patient-centered design
Industry2 codes
1Wearable Injectors & On-Body Delivery Systems
CodeHLAHAIAEPrimaryYes
2Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
CodeHLAHAIAMPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Drug Infusion Devices
No data
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Zuuka is developing a next-generation wearable drug infusion device designed for reliable drug delivery in patients requiring infusion therapy. The product emphasizes smarter systems, simpler interfaces, modern design, and hardware built for real-life use, addressing usability, simplicity, and sustainability gaps in current wearable infusion solutions. The device is currently in development and has not received regulatory approval for sale in any international market.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Zuuka is developing a single unified product: a next-generation wearable drug infusion device. The company is focused on redesigning wearable drug infusion technology with an emphasis on smarter systems, simpler interfaces, and environmentally sustainable hardware designed for real-life use. The product is not yet available for purchase and has not received regulatory approval in any market.

Product and service1 record
1Wearable Drug Infusion Solution
CategoryWearable drug infusion device
Description

A next-generation wearable drug infusion device designed with smarter systems, simpler interfaces, and hardware built for real-life use. The product targets patients who require reliable drug delivery to improve quality of life, addressing usability, simplicity, modern design, and environmental sustainability. The solution is currently in development and has not received regulatory approval for sale in any international market.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Medtronic
TypeBroad incumbent
Description

Global medical device incumbent with MiniMed insulin pumps and broader infusion portfolio. A scaled incumbent against which any new wearable infusion entrant must differentiate on UX, form factor, or service model.

2Insulet Corporation
TypeDirect peer
Description

Maker of the Omnipod tubeless wearable insulin pump. Closest direct peer as a pure-play wearable drug infusion device company competing for the same patient population.

3CeQur
TypeDirect peer
Description

Develops a wearable insulin patch (PaQ). Small, design-led peer competing on form factor and simplicity for mealtime insulin delivery.

4Tandem Diabetes Care
TypeDirect peer
Description

Maker of the t:slim X2 insulin pump, focused on touch-screen, design-forward pumps. Direct competitor in the user-experience-led segment Zuuka is targeting.

5Abbott Diabetes Care
TypeBroad incumbent
Description

Makes FreeStyle Libre CGM and adjacent diabetes devices. Adjacent incumbent shaping expectations for wearable, app-connected drug delivery experiences.

6Ypsomed
TypeDirect peer
Description

Swiss maker of the mylife Wearable Infusion System / YpsoPump. Closely comparable European-headquartered wearable infusion player with overlapping design-led positioning.

7Enable Injections
TypeEmerging player
Description

Develops the enFuse wearable large-volume injector for biologics. Comparable emerging peer pursuing wearable delivery for non-insulin biologics - directly overlaps Zuuka's beyond-diabetes potential.

8SOOIL Development
TypeDirect peer
Description

Korean maker of the Dana Diabecare wearable insulin pump. Comparable wearable pump peer focused on compact form factor for global markets.

9Roche Diabetes Care
TypeBroad incumbent
Description

Operates Accu-Chek insulin delivery systems and broader diabetes management portfolio. Incumbent competitor with established payer and clinician relationships Zuuka must overcome.

10Sorrel Medical
TypeEmerging player
Description

Israel-based developer of a wearable drug delivery platform for biologics. Emerging peer in the wearable large-molecule delivery space, comparable in stage and ambition to Zuuka.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zuuka Group

Wearable Drug Infusion Deviceszuuka.com

Zuuka Group firmographics

Firmographics
Name
Zuuka Group
Legal name
Zuuka Limited
Website
https://zuuka.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Zuuka Group industry classification

Industry
Product category
Wearable Drug Infusion Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Wearable Injectors & On-Body Delivery Systems (HLAHAIAE)
akta.pro secondary industry
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM)

Keywords

  • Wearable drug infusion
  • Medical device development
  • Drug delivery systems
  • Infusion technology
  • Patient-centered design

Where Zuuka Group is headquartered

Location

Headquarters

HQ city
Offenbach
HQ country
Germany
HQ region
Europe

Markets served

Zuuka Group business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Marketing channels1 record

Zuuka Group product offering

Product offering

Core offering

Zuuka is developing a next-generation wearable drug infusion device designed for reliable drug delivery in patients requiring infusion therapy. The product emphasizes smarter systems, simpler interfaces, modern design, and hardware built for real-life use, addressing usability, simplicity, and sustainability gaps in current wearable infusion solutions. The device is currently in development and has not received regulatory approval for sale in any international market.

Product overview

Zuuka is developing a single unified product: a next-generation wearable drug infusion device. The company is focused on redesigning wearable drug infusion technology with an emphasis on smarter systems, simpler interfaces, and environmentally sustainable hardware designed for real-life use. The product is not yet available for purchase and has not received regulatory approval in any market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Wearable Drug Infusion Solution A next-generation wearable drug infusion device designed with smarter systems, simpler interfaces, and hardware built for real-life use. The product targets patients who require reliable drug delivery to improve quality of life, addressing usability, simplicity, modern design, and environmental sustainability. The solution is currently in development and has not received regulatory approval for sale in any international market.

Companies that use Zuuka Group

Customer profile

Segments1 record

Ideal customer profiles1 record

Zuuka Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Zuuka Group partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Zuuka Group competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Global medical device incumbent with MiniMed insulin pumps and broader infusion portfolio. A scaled incumbent against which any new wearable infusion entrant must differentiate on UX, form factor, or service model.
  • Abbott Diabetes Care: Makes FreeStyle Libre CGM and adjacent diabetes devices. Adjacent incumbent shaping expectations for wearable, app-connected drug delivery experiences.
  • Roche Diabetes Care: Operates Accu-Chek insulin delivery systems and broader diabetes management portfolio. Incumbent competitor with established payer and clinician relationships Zuuka must overcome.

Direct peers

  • Insulet Corporation: Maker of the Omnipod tubeless wearable insulin pump. Closest direct peer as a pure-play wearable drug infusion device company competing for the same patient population.
  • CeQur: Develops a wearable insulin patch (PaQ). Small, design-led peer competing on form factor and simplicity for mealtime insulin delivery.
  • Tandem Diabetes Care: Maker of the t:slim X2 insulin pump, focused on touch-screen, design-forward pumps. Direct competitor in the user-experience-led segment Zuuka is targeting.
  • Ypsomed: Swiss maker of the mylife Wearable Infusion System / YpsoPump. Closely comparable European-headquartered wearable infusion player with overlapping design-led positioning.
  • SOOIL Development: Korean maker of the Dana Diabecare wearable insulin pump. Comparable wearable pump peer focused on compact form factor for global markets.

Emerging players

  • Enable Injections: Develops the enFuse wearable large-volume injector for biologics. Comparable emerging peer pursuing wearable delivery for non-insulin biologics - directly overlaps Zuuka's beyond-diabetes potential.
  • Sorrel Medical: Israel-based developer of a wearable drug delivery platform for biologics. Emerging peer in the wearable large-molecule delivery space, comparable in stage and ambition to Zuuka.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Zuuka Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zuuka Group leadership team

Management profile

Number of profiles

Profiles3 records

Zuuka Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zuuka Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zuuka Group

What does Zuuka Group do?

Zuuka is developing a next-generation wearable drug infusion device designed for reliable drug delivery in patients requiring infusion therapy. The product emphasizes smarter systems, simpler interfaces, modern design, and hardware built for real-life use, addressing usability, simplicity, and sustainability gaps in current wearable infusion solutions. The device is currently in development and has not received regulatory approval for sale in any international market.

Is Zuuka Group a public or private company?

Zuuka Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Zuuka Group founded?

Zuuka Group was founded in 2001. It employs 11 to 50 people.

Where is Zuuka Group based?

Zuuka Group is headquartered in Offenbach, Germany, in the Europe region.

Who are Zuuka Group's main competitors?

Broad incumbents on record are Medtronic, Abbott Diabetes Care and Roche Diabetes Care. Direct peers are Insulet Corporation, CeQur, Tandem Diabetes Care, Ypsomed and SOOIL Development. Emerging players are Enable Injections and Sorrel Medical.

Does Zuuka Group have an API?

No public API is recorded for Zuuka Group.

What industry is Zuuka Group in?

Zuuka Group's product category is Wearable Drug Infusion Devices. Its primary akta.pro industry code is HLAHAIAE, Wearable Injectors & On-Body Delivery Systems, with a secondary code of HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals